Substances · Lysergamides
LSD-25
- Preferred name
- LSD-25
- IUPAC name
- (6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Parent CAS number (reference)
- 50-37-3
- Molecular formula
- C20H25N3O
- Molecular weight
- 323.4 g/mol
- InChIKey
- VAYOSLLFUXYJDT-RDTXWAMCSA-N
- PubChem
- CID 5761
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Lysergide Lysergic acid diethylamide LSD LSD25
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
LSD-25
Receptor Telemetry & Mechanism of Action
Prototypical ergoline partial agonist at 5-HT2A (Ki ~2.9 nM) with prolonged receptor 'lid' residence time (Wacker et al., Cell 2017) plus 5-HT1A and D2 signaling.
Biotransformation & Active Metabolites
Hepatic CYP2D6/3A4/1A2 oxidation to inactive 2-oxo-3-hydroxy-LSD (plasma T1/2 ~3.6 h).
Temporal Pharmacokinetics
Reference Lysergamide (5-HT2A/1A/2C & D2 Agonist) — Supplied strictly as calibrated dissolved liquid solution (never paper blotters); serves as the 1:1 molar benchmark for 1P-LSD (~0.85x), 1cP-LSD (~0.82x), and 1V-LSD (~0.79x).
- Onset 30–60 min
- Peak Window 2–4 h
- Total Window 8–12 h
- Residual / Half-Life 4–8 h residual wakefulness
Supplied strictly as calibrated dissolved liquid solution (never paper blotters); serves as the 1:1 molar benchmark for 1P-LSD (~0.85x), 1cP-LSD (~0.82x), and 1V-LSD (~0.79x).
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
10–20 ug
Subtle threshold receptor activity (Reference Lysergamide (5-HT2A/1A/2C & D2 Agonist)).
Minimal baseline autonomic shift.
25–75 ug
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
75–150 ug
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
150–300 ug
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
300+ ug
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.
Lowers seizure threshold alongside 5-HT2A excitation.
Elevated Hazard — Avoid
Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.
Caution / Receptor Attenuation
Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.
Structural Isomer & Sibling Comparison
Supplied strictly as calibrated dissolved liquid solution (never paper blotters); serves as the 1:1 molar benchmark for 1P-LSD (~0.85x), 1cP-LSD (~0.82x), and 1V-LSD (~0.79x).
Physicochemical Stability & Storage
Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.
Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.
Cross-Tolerance & Dependence Profile
Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.
Chemical Architecture & Structural Profile
LSD-25 ((6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide) is a reference compound belonging to the Lysergamides class, characterized by the molecular formula C20H25N3O and a molar mass of 323.4 g/mol. The parent molecule is indexed under CAS registry number 50-37-3 and in the NCBI PubChem database as CID 5761 (Standard InChIKey: VAYOSLLFUXYJDT-RDTXWAMCSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), LSD-25 is indexed within the Lysergamides structural group. Toxicological notes (PsychonautWiki): extremely low toxicity relative to dose. Dependence liability (PsychonautWiki): non-addictive with a low abuse potential. Documented cross-tolerance class: psychedelics. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (AE) — National Regulatory Authority (AE) (2026-11-12)